Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 172

1.

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations.

Rich TA, Reckamp KL, Chae YK, Doebele RC, Iams WT, Oh M, Raymond VM, Lanman RB, Riess JW, Stinchcombe TE, Subbiah V, Trevarthen DR, Fairclough S, Yen J, Gautschi O.

Clin Cancer Res. 2019 Jul 12. doi: 10.1158/1078-0432.CCR-18-4049. [Epub ahead of print]

PMID:
31300450
2.

CDC73-Related Disorders.

Hyde SM, Rich TA, Waguespack SG, Perrier ND, Hu MI.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2008 Dec 31 [updated 2018 Apr 26].

3.

Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma.

Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL Jr, Waguespack SG, Perrier ND, Grubbs EG.

Ann Surg Oncol. 2018 May;25(5):1395-1402. doi: 10.1245/s10434-018-6366-0. Epub 2018 Feb 9.

PMID:
29427212
4.

TCCC Guidelines Comprehensive Review and Update: TCCC Guidelines Change 16-03.

Montgomery HR, Butler FK, Kerr W, Conklin CC, Morissette DM, Remley MA, Shaw TA, Rich TA.

J Spec Oper Med. 2017 Summer;17(2):21-38.

PMID:
28599032
5.

Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation.

Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Sellin RV, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ.

Thyroid. 2016 Dec;26(12):1744-1751. Epub 2016 Oct 18.

6.

Assessment of Cardiovascular Parameters during Meditation with Mental Targeting in Varsity Swimmers.

Rich TA, Pfister R, Alton J, Gerdt D, Baruch M.

Evid Based Complement Alternat Med. 2016;2016:7923234. doi: 10.1155/2016/7923234. Epub 2016 Feb 11.

7.

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.

Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson AB 3rd, Mayer RJ, Cripps CM, Danenberg K, Makar KW, Zhang W, Benedetti JK, Lenz HJ.

Clin Cancer Res. 2015 Apr 1;21(7):1583-90. doi: 10.1158/1078-0432.CCR-14-0857. Epub 2015 Jan 14.

8.

Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.

Romero Arenas MA, Fowler RG, San Lucas FA, Shen J, Rich TA, Grubbs EG, Lee JE, Scheet P, Perrier ND, Zhao H.

Surgery. 2014 Dec;156(6):1351-7; discussion 1357-8. doi: 10.1016/j.surg.2014.08.073. Epub 2014 Nov 11.

9.

Paragangliomas Arising in the Head and Neck: A Morphologic Review and Genetic Update.

Williams MD, Rich TA.

Surg Pathol Clin. 2014 Dec;7(4):543-57. doi: 10.1016/j.path.2014.08.007. Epub 2014 Nov 8. Review.

PMID:
26837554
10.

Hereditary breast cancer syndromes and genetic testing.

Rich TA, Woodson AH, Litton J, Arun B.

J Surg Oncol. 2015 Jan;111(1):66-80. doi: 10.1002/jso.23791. Epub 2014 Nov 7. Review.

PMID:
25381882
11.

Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism.

Romero Arenas MA, Morris LF, Rich TA, Cote GJ, Grubbs EG, Waguespack SG, Perrier ND.

J Pediatr Surg. 2014 Apr;49(4):546-50. doi: 10.1016/j.jpedsurg.2013.11.059. Epub 2013 Nov 27.

PMID:
24726110
12.

Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.

Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying A, Grubbs E.

Thyroid. 2014 Jul;24(7):1096-106. doi: 10.1089/thy.2013.0620. Epub 2014 Jun 6.

13.

Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.

Rich TA, Liu M, Etzel CJ, Bannon SA, Mork ME, Ready K, Saraiya DS, Grubbs EG, Perrier ND, Lu KH, Arun BK, Woodard TL, Schover LR, Litton JK.

Fam Cancer. 2014 Jun;13(2):291-9. doi: 10.1007/s10689-013-9685-0.

14.

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.

Gunderson LL, Moughan J, Ajani JA, Pedersen JE, Winter KA, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):638-45. doi: 10.1016/j.ijrobp.2013.07.035. Epub 2013 Sep 10.

15.

Long-term outcomes of surgical treatment for hereditary pheochromocytoma.

Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND.

J Am Coll Surg. 2013 Feb;216(2):280-9. doi: 10.1016/j.jamcollsurg.2012.10.012.

PMID:
23317575
16.

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.

J Clin Oncol. 2012 Dec 10;30(35):4344-51. doi: 10.1200/JCO.2012.43.8085. Epub 2012 Nov 13.

17.

Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

Willett CG, Moughan J, O'Meara E, Galvin JM, Crane CH, Winter K, Manfredi D, Rich TA, Rabinovitch R, Lustig R, Machtay M, Curran WJ.

Radiother Oncol. 2012 Oct;105(1):9-13. doi: 10.1016/j.radonc.2012.09.011. Epub 2012 Oct 17.

18.

Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.

Rich TA, Winter K, Safran H, Hoffman JP, Erickson B, Anne PR, Myerson RJ, Cline-Burkhardt VJ, Perez K, Willett C.

Onco Targets Ther. 2012;5:161-70. doi: 10.2147/OTT.S33560. Epub 2012 Aug 23.

19.

Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.

Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG.

Ann Surg Oncol. 2013 Jan;20(1):53-9. doi: 10.1245/s10434-012-2589-7. Epub 2012 Aug 14.

20.

Does external beam radiation therapy improve survival following transarterial chemoembolization for unresectable hepatocellular carcinoma?

Cupino AC, Hair CD, Angle JF, Caldwell SH, Rich TA, Berg CL, Northup PG, Al-Osaimi AM, Argo CK.

Gastrointest Cancer Res. 2012 Jan;5(1):13-7.

Supplemental Content

Support Center